Neuroprotective properties of solanum leaves in transgenic Drosophila melanogaster model of Alzheimer's disease

References

• Abolaji, A., et al., 2013. Drosophila melanogaster as a Promising Model Organism in Toxicological Studies: A Mini Review Ameliorative Properties of Citrus Bioflavonoids on 4-vinylcyclohexene diepoxide (VCD)-induced reprotoxicity View project Nigerian Drosophila Research Community V. Archives of basic and applied medicine, 1, 33–38.
   Google Scholar
• Abolaji, A.O., et al., 2017. Dietary consumption of monosodium L-glutamate induces adaptive response and reduction in the life span of Drosophila melanogaster. Cell biochemistry and function, 35 (3), 164–170.
   PubMed Web of Science ®Google Scholar
• Abolaji, A.O., et al., 2018. Resveratrol prolongs lifespan and improves 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced oxidative damage and behavioural deficits in Drosophila melanogaster. Biochemical and biophysical research communications, 503 (2), 1042–1048.
   PubMed Web of Science ®Google Scholar
• Adedara, I.A., et al., 2016. Diphenyl diselenide protects against mortality, locomotor deficits and oxidative stress in drosophila melanogaster model of manganese-induced neurotoxicity. Neurochemical research, 41 (6), 1430–1438.
   PubMed Web of Science ®Google Scholar
• Adedayo, B.C., et al., 2022. Effect of Andrographis paniculata and Phyllanthus amarus leaf extracts on selected biochemical indices in Drosophila melanogaster model of neurotoxicity. Drug and chemical toxicology, 45 (1), 407–416.
   PubMed Web of Science ®Google Scholar
• Ali, F., et al., 2019. Therapeutic potential of luteolin in transgenic Drosophila model of Alzheimer’s disease. Neuroscience letters, 692, 90–99.
   PubMed Web of Science ®Google Scholar
• Ali, Y.O., et al., 2011. Assaying locomotor, learning, and memory deficits in Drosophila models of neurodegeneration. Journal of visualized experiments, 49, 2504.
   Google Scholar
• Andrés, N., et al., 2001. Tissue activity and cellular localization of human semicarbazide-sensitive amine oxidase. Journal of histochemistry and cytochemistry, 49 (2), 209–217.
   PubMed Web of Science ®Google Scholar
• Arai, T., et al., 2016. Inhibition of amyloid fibril formation and cytotoxicity by caffeic acid-conjugated amyloid-β C-terminal peptides. Bioorganic and medicinal chemistry letters, 26 (22), 5468–5471.
   PubMed Web of Science ®Google Scholar
• Bolea, I., Gella, A., and Unzeta, M., 2013. Propargylamine-derived multitarget-directed ligands: Fighting Alzheimer’s disease with monoamine oxidase inhibitors. Journal of neural transmission, 120 (6), 893–902.
   PubMed Web of Science ®Google Scholar
• Bourdel-Marchasson, I., et al., 2001. Antioxidant defences and oxidative stress markers in erythrocytes and plasma from normally nourished elderly Alzheimer patients. Age and ageing, 30(3), 235–241.
   PubMed Web of Science ®Google Scholar
• Bushway, R.J., Savage, S.A., and Ferguson, B.S., 1987. Inhibition of acetyl cholinesterase by solanaceous glycoalkaloids and alkaloids. American potato journal, 64 (8), 409–413.
   Google Scholar
• Cai, H.Y., et al., 2014. Lixisenatide rescues spatial memory and synaptic plasticity from amyloid β protein-induced impairments in rats. Neuroscience. Neuroscience, 277, 6–13.,
   PubMed Web of Science ®Google Scholar
• Chakraborty, R., et al., 2011. Characterization of a drosophila Alzheimer’s disease model: Pharmacological rescue of cognitive defects. PLoS one, 6 (6), e20799.,
   PubMed Web of Science ®Google Scholar
• Chen, X., Guo, C., and Kong, J., 2012. Oxidative stress in neurodegenerative diseases. Neural regeneration research, 7 (5), 376.
   Web of Science ®Google Scholar
• Christen, Y., 2000. Oxidative stress and Alzheimer disease. American journal of clinical nutrition, 71 (2), 621S–629S.
   Web of Science ®Google Scholar
• Citron, M., 2004. β-Secretase inhibition for the treatment of Alzheimer’s disease - Promise and challenge. Trends in pharmacological sciences, 25 (2), 92–97.
   PubMed Web of Science ®Google Scholar
• Cosín-Tomàs, M., et al., 2019. Role of resveratrol and selenium on oxidative stress and expression of antioxidant and anti-aging genes in immortalized lymphocytes from Alzheimer’s disease patients. Nutrients, 11 (8), 1764.
   Web of Science ®Google Scholar
• Du, X., Wang, X., and Geng, M., 2018. Alzheimer's disease hypothesis and related therapies. Translational Neurodegeneration, 7, 2.
   Google Scholar
• Ellman, G.L., 1959. Tissue sulfhydryl groups. Archives of biochemistry and biophysics, 82 (1), 70–77.
   PubMed Web of Science ®Google Scholar
• Ellman, G.L., et al., 1961. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochemical pharmacology, 7 (2), 88–95.
   PubMed Web of Science ®Google Scholar
• Foley, P., et al., 2000. MAO-B inhibitors: Multiple roles in the therapy of neurodegenerative disorders? Parkinsonism and related disorders, 6 (1), 25–47.
   PubMed Web of Science ®Google Scholar
• Fortini, M.E., et al., 2000. A survey of human disease gene counterparts in the Drosophila genome. Journal of cell biology, 150 (2), F23–F30.
   PubMed Web of Science ®Google Scholar
• Frank, B., and Gupta, S., 2005. A review of antioxidants and Alzheimer's disease. Annals of clinical psychiatry, 17 (4), 269–286.
   PubMedGoogle Scholar
• Greeve, I., 2004. Age-dependent neurodegeneration and alzheimer-amyloid plaque formation in transgenic drosophila. Journal of neuroscience, 24 (16), 3899–3906.
   PubMed Web of Science ®Google Scholar
• Grundman, M., and Delaney, P., 2002. Antioxidant strategies for Alzheimer’s disease. Proceedings of the nutrition society, 61 (2), 191–202.
   PubMed Web of Science ®Google Scholar
• Gupta, V.B., and Rao, K.S.J., 2007. Anti-amyloidogenic activity of S-allyl-l-cysteine and its activity to destabilize Alzheimer’s β-amyloid fibrils in vitro. Neuroscience letters, 429 (2-3), 75–80.
   PubMed Web of Science ®Google Scholar
• Habig, W.H., and Jakoby, W.B., 1981. Assays for differentiation of glutathione S-transferases. Methods in enzymology, 77, 398–405.
   PubMedGoogle Scholar
• Haliński, ŁP., et al., 2012. The chemical composition of cuticular waxes from leaves of the gboma eggplant (Solanum macrocarpon L.). Journal of food composition and analysis, 25 (1), 74–78.
   Web of Science ®Google Scholar
• Hu, W., Gray, N.W., and Brimijoin, S., 2004. Amyloid-beta increases acetylcholinesterase expression in neuroblastoma cells by reducing enzyme degradation. Journal of neurochemistry, 86 (2), 470–478.
   Web of Science ®Google Scholar
• Huang, L., et al., 2012. Multitarget-directed benzylideneindanone derivatives: Anti-β-amyloid (Aβ) aggregation, antioxidant, metal chelation, and monoamine oxidase B (MAO-B) inhibition properties against Alzheimer’s disease. Journal of medicinal chemistry, 55 (19), 8483–8492.,
   PubMed Web of Science ®Google Scholar
• Huang, W.J., Zhang, X., and Chen, W.W., 2016. Role of oxidative stress in Alzheimer's disease. ).Biomedical reports, 4 (5), 519–522.
   PubMed Web of Science ®Google Scholar
• Huang, Y., et al., 2013. Protective effects of caffeic acid and caffeic acid phenethyl ester against acrolein-induced neurotoxicity in HT22 mouse hippocampal cells. Neuroscience letters, 535, 146–151
   PubMed Web of Science ®Google Scholar
• Iijima-Ando, K., and Iijima, K., 2010. Transgenic drosophila models of Alzheimer’s disease and tauopathies. Brain structure & function, 214 (2-3), 245–262.
   PubMed Web of Science ®Google Scholar
• Islam, M.T., 2017. Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders. Neurological research, 39 (1), 73–82.
   PubMed Web of Science ®Google Scholar
• Jain, R., et al., 2011. Solanum nigrum: Current perspectives on therapeutic properties. Alternative medicine review, 16 (1), 78–85.
   PubMedGoogle Scholar
• Kiełczewska, U., et al., 2021. The synthesis and cholinesterase inhibitory activities of solasodine analogues with seven-membered F ring. The journal of steroid biochemistry and molecular biology, 205, 105776.,
   PubMed Web of Science ®Google Scholar
• Kim, J.H., Kim, G.H., and Hwang, K.H., 2012. Monoamine oxidase and dopamine β-hydroxylase inhibitors from the fruits of Gardenia jasminoides. Biomolecules & therapeutics, 20 (2), 214–219.
   PubMed Web of Science ®Google Scholar
• Kivrak, E., et al., 2017. Effects of electromagnetic fields exposure on the antioxidant defense system. Journal of microscopy and ultrastructure, 5 (4), 167.
   PubMedGoogle Scholar
• Klafki, H.W., et al., 2006. Therapeutic approaches to Alzheimer's disease. Brain, 129 (Pt 11), 2840–2855.
   PubMedGoogle Scholar
• Kong, L.D., Cheng, C.H.K., and Tan, R.X., 2004. Inhibition of MAO a and B by some plant-derived alkaloids, phenols and anthraquinones. Journal of ethnopharmacology, 91 (2-3), 351–355.
   PubMed Web of Science ®Google Scholar
• Kumar, S., Okello, E.J., and Harris, J.R., 2012. Experimental inhibition of fibrillogenesis and neurotoxicity by amyloid-beta (Aβ) and other disease-related peptides/proteins by plant extracts and herbal compounds. Subcellular biochemistry, 65, 295–326.
   PubMedGoogle Scholar
• Lee, K.S., et al., 2010. Curcumin extends life span, improves health span, and modulates the expression of age-associated aging genes in drosophila melanogaster. Rejuvenation research, 13 (5), 561–570.,
   PubMed Web of Science ®Google Scholar
• Loreto, LMNSeÉLS., 2019. 2010: um século de Drosophila na Genética. Genética na escola, 5, 2.
   Google Scholar
• Lovell, M.A., Xie, C., and Markesbery, W.R., 1998. Decreased glutathione transferase activity in brain and ventricular fluid in Alzheimer’s disease. Neurology, 51 (6), 1562–1566.
   PubMed Web of Science ®Google Scholar
• Maggiorani, D., et al., 2017. Monoamine oxidases, oxidative stress, and altered mitochondrial dynamics in cardiac ageing. Oxidative medicine and cellular longevity, 2017, 3017947.,
   PubMed Web of Science ®Google Scholar
• Mancini, F., et al., 2007. Multiwell fluorometric and colorimetric microassays for the evaluation of beta-secretase (BACE-1) inhibitors. Analytical and bioanalytical chemistry, 388 (5-6), 1175–1183.
   PubMed Web of Science ®Google Scholar
• Mazzio, E., et al., 2013. High throughput screening to identify natural human monoamine oxidase B inhibitors. Phytotherapy research, 27 (6), 818–828.
   PubMed Web of Science ®Google Scholar
• Mhatre, S.D., et al., 2014a. Synaptic abnormalities in a Drosophila model of Alzheimer’s disease. DMM disease models and mechanisms, 7(3), 373–785.
   PubMed Web of Science ®Google Scholar
• Mhatre, S.D., et al., 2014b. Development and characterization of an aged onset model of Alzheimer’s disease in Drosophila melanogaster. Experimental neurology, 261, 772–781.
   PubMed Web of Science ®Google Scholar
• Mori, T., et al., 2013. Ferulic acid is a nutraceutical β-secretase modulator that improves behavioral impairment and alzheimer-like pathology in transgenic mice. PLoS one, 8 (2), e55774.
   PubMed Web of Science ®Google Scholar
• Neff, N.H., and Yang, H.Y.T., 1974. Another look at the monoamine oxidases and the monoamine oxidase inhibitor drugs. Life sciences, 14 (11), 2061–2074.
   PubMed Web of Science ®Google Scholar
• Noguchi-Shinohara, M., et al., 2018. Higher blood vitamin C levels are associated with reduction of apolipoprotein e e4-related risks of cognitive decline in women: the Nakajima study. Journal of alzheimer's disease, 63 (4), 1289–1297.,
   PubMed Web of Science ®Google Scholar
• Oboh, G., Ekperigin, M.M., and Kazeem, M.I., 2005. Nutritional and haemolytic properties of eggplants (Solanum macrocarpon) leaves. Journal of food composition and analysis, 18 (2-3), 153–160.
   Web of Science ®Google Scholar
• Oboh, G., et al., 2018. Effect of alkaloid extract from african jointfir (Gnetum africanum) leaves on manganese-induced toxicity in Drosophila melanogaster. Oxidative medicine and cellular longevity, 2018, 8952646.
   PubMed Web of Science ®Google Scholar
• Oboh, G., et al., 2022. Characterization and neuroprotective properties of alkaloid extract of Vernonia amygdalina Delile in experimental models of Alzheimer’s disease. Drug and chemical toxicology, 45 (2), 710–731.
   Web of Science ®Google Scholar
• Ogunruku, O.O., et al., 2017. Capsicum annuum var. grossum (Bell Pepper) Inhibits β-Secretase Activity and β-Amyloid1-40 Aggregation. Journal of medicinal food, 20 (2), 124–130.
   PubMed Web of Science ®Google Scholar
• Ogunsuyi, O.B., Ademiluyi, A.O., and Oboh, G., 2020. Solanum leaves extracts exhibit antioxidant properties and inhibit monoamine oxidase and acetylcholinesterase activities (in vitro) in Drosophila melanogaster. Journal of basic and clinical physiology and pharmacology, 31 (3), 20190256.
   PubMedGoogle Scholar
• Ogunsuyi, O.B., et al., 2018. Green leafy vegetables from two Solanum spp. (Solanum nigrum L and Solanum macrocarpon L) ameliorate scopolamine-induced cognitive and neurochemical impairments in rats. Food science & nutrition, 6 (4), 860–870.
   PubMed Web of Science ®Google Scholar
• Ogunsuyi, O.B., et al., 2021a. Dietary inclusions of Solanum vegetables mitigate aluminum-induced redox and inflammation-related neurotoxicity in Drosophila melanogaster model. Nutritional neuroscience. https://doi.org/10.1080/1028415X.2021.1933331
   Google Scholar
• Ogunsuyi, O.B., et al., 2021b. Solanum vegetable-based diets improve impairments in memory, redox imbalance, and altered critical enzyme activities in Drosophila melanogaster model of neurodegeneration. Journal of food biochemistry, 45 (3), e13150.
   PubMed Web of Science ®Google Scholar
• Ogunsuyi, O.B., et al., 2022. Effect of Solanum vegetables on memory index, redox status, and expressions of critical neural genes in Drosophila melanogaster model of memory impairment. Metabolic brain disease, 37 (3), 729–741.,
   PubMed Web of Science ®Google Scholar
• Ohkawa, H., Ohishi, N., and Yagi, K., 1979. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical biochemistry, 95 (2), 351–358.
   PubMed Web of Science ®Google Scholar
• Ortiz, J.E., et al., 2018. Cholinesterase-inhibitory effect and in silico analysis of alkaloids from bulbs of Hieronymiella species. Phytomedicine , 39, 66–74.,
   PubMed Web of Science ®Google Scholar
• Özdemir, Z., et al., 2021. Monoamine oxidase-B (MAO-B) inhibitors in the treatment of alzheimer’s and parkinson’s disease. Current medicinal chemistry, 28 (29), 6045–6065.
   PubMed Web of Science ®Google Scholar
• Pérez-Severiano, F., et al., 2004. Increased formation of reactive oxygen species, but no changes in glutathione peroxidase activity, in striata of mice transgenic for the huntington’s disease mutation. Neurochemical research, 29 (4), 729–733.
   PubMed Web of Science ®Google Scholar
• Periyanayagam, K., et al., 2015. Protective effect of the leaves of Solanum torvums wartz on Drosophila melanogaster against ß-amyloid induced alzheimer disease. Research journal of pharmacy and technology, 8 (6), 719.
   Google Scholar
• Picciotto, M. R., Higley, M. J., and Mineur, Y. S., 2012. Acetylcholine as a neuromodulator: cholinergic signaling shapes nervous system function and behavior. Neuron, 76, 116–129.
   Google Scholar
• Prüßing, K., Voigt, A., and Schulz, J.B., 2013. Drosophila melanogaster as a model organism for Alzheimer’s disease. Molecular neurodegeneration, 8 (1), 35.
   PubMedGoogle Scholar
• Rice-Evans, C.A., Miller, N.J., and Paganga, G., 1997. Antioxidant properties of phenolic compounds. Trends in plant science, 2 (4), 152–159.
   Web of Science ®Google Scholar
• Riemensperger, T., et al., 2011. Behavioral consequences of dopamine deficiency in the Drosophila central nervous system. Proceedings of the national academy of sciences, 108 (2), 834–839.,
   PubMed Web of Science ®Google Scholar
• Saharan, S., and Mandal, P.K., 2014. The emerging role of glutathione in Alzheimer’s disease. Journal of alzheimer’s disease, 40 (3), 519–529.
   PubMed Web of Science ®Google Scholar
• Sberna, G., et al., 1998. Acetylcholinesterase is increased in the brains of transgenic mice expressing the C-terminal fragment (CT100) of the β-amyloid protein precursor of Alzheimer’s disease. Journal of neurochemistry, 71 (2), 723–731.
   PubMed Web of Science ®Google Scholar
• Schedin-Weiss, S., et al., 2017. Monoamine oxidase B is elevated in Alzheimer disease neurons, is associated with γ-secretase and regulates neuronal amyloid β-peptide levels. Alzheimer’s research and therapy, 9 (1), 57.
   PubMedGoogle Scholar
• Shahidi, F., and Ambigaipalan, P., 2015. Phenolics and polyphenolics in foods, beverages and spices: Antioxidant activity and health effects - A review. Journal of functional foods, 18, 820–897.
   Web of Science ®Google Scholar
• Sinha, A.K., 1972. Colorimetric assay of catalase. Analytical biochemistry, 47 (2), 389–394.
   PubMed Web of Science ®Google Scholar
• Sul, D., et al., 2009. Protective effect of caffeic acid against beta-amyloid-induced neurotoxicity by the inhibition of calcium influx and tau phosphorylation. Life sciences, 84 (9-10), 257–262.
   PubMed Web of Science ®Google Scholar
• Thomas, T., 2000. Monoamine oxidase-B inhibitors in the treatment of Alzheimers disease. Neurobiology of aging, 21 (2), 343–348.
   PubMed Web of Science ®Google Scholar
• Tönnies, E., and Trushina, E., 2017. Oxidative stress, synaptic dysfunction, and Alzheimer’s disease. Journal of alzheimer’s disease, 57 (4), 1105–1121.
   PubMed Web of Science ®Google Scholar
• Turski, W., Turska, E., and Gross Bellard, M., 1972. Modification of the spectrophotometric method of the determination of monoamine oxidase. Enzyme, 14 (4), 211–220.
   Google Scholar
• Ugur, B., Chen, K., and Bellen, H.J., 2016. Drosophila tools and assays for the study of human diseases. DMM disease models and mechanisms, 9 (3), 235–244.
   PubMed Web of Science ®Google Scholar
• Van Dam, D., and De Deyn, P.P., 2006. Drug discovery in dementia: The role of rodent models. Nature reviews. Drug discovery, 5 (11), 956–970.
   PubMed Web of Science ®Google Scholar
• Vassar, R., et al., 2004. The β-secretase enzyme BACE in health and Alzheimer's disease: regulation, cell biology, function, and therapeutic potential. Journal of neuroscience, 29(41), 12787–12794.
   Google Scholar
• Xie, Q., et al., 2008. Bis-(-)-nor-meptazinols as novel nanomolar cholinesterase inhibitors with high inhibitory potency on amyloid-β aggregation. Journal of medicinal chemistry, 51 (7), 2027–2036.,
   PubMed Web of Science ®Google Scholar
• Yamaguchi, M., et al., 2021. Drosophila models to study causative genes for human rare intractable neurological diseases. Experimental cell research, 403 (1), 112584.
   PubMed Web of Science ®Google Scholar
• Yan, R., and Vassar, R., 2014. Targeting the β secretase BACE1 for Alzheimer’s disease therapy. The lancet. Neurology, 13 (3), 319–329.
   PubMed Web of Science ®Google Scholar
• Ye, Y., and Fortini, M.E., 1999. Apoptotic activities of wild-type and Alzheimer’s disease-related mutant presenilins in Drosophila melanogaster. Journal of cell biology, 146 (6), 1351–1364.
   PubMed Web of Science ®Google Scholar
• Yeh, T.S., et al., 2021. Long-term dietary flavonoid intake and subjective cognitive decline in us men and women. Neurology, 97 (23), 1095–1095.
   PubMedGoogle Scholar
• Youn, K., and Jun, M., 2012. Inhibitory effects of key compounds isolated from Corni fructus on bace1 activity. Phytotherapy research : ptr, 26 (11), 1714–1718.
   PubMed Web of Science ®Google Scholar
• Youn, K., et al., 2016. Discovery of polymethoxyflavones from black ginger (Kaempferia parviflora) as potential β-secretase (BACE1) inhibitors. Journal of functional foods, 20, 567–574.
   Web of Science ®Google Scholar